FREMONT, Calif., Feb. 28 /PRNewswire-FirstCall/ -- PDL BioPharma, Inc. (PDL) today announced that it will make available a live webcast of its presentation at the Citigroup Global Healthcare Conference in Washington, D.C. The live webcast will begin at 9:45 a.m. Eastern time on March 1, 2006. The presentation will be made by Mark McDade, Chief Executive Officer. The live audio webcast of the presentation will be available to all interested parties through the PDL website at www.pdl.com. Please connect to this website at least 15 minutes prior to the live webcast to allow time for any software download that may be needed to hear the webcast. A replay will be available at www.pdl.com starting approximately 24 hours after completion of the live webcast, and will remain available for 30 days thereafter.
PDL BioPharma, Inc. is a biopharmaceutical company focused on discovering, developing and commercializing innovative therapies for severe or life threatening illnesses. The company currently markets and sells a portfolio of leading products in the acute-care hospital setting in the United States and Canada and generates royalties through licensing agreements with top-tier biotechnology and pharmaceutical companies based on its pioneering humanized antibody technology. Currently, PDL BioPharma's diverse late-stage product pipeline includes six investigational compounds in Phase 2 or Phase 3 clinical development for hepatorenal syndrome, inflammation and autoimmune diseases, cardiovascular disorders and cancer. For more information, please see our website at www.pdl.com.
NOTE: PDL BioPharma and the PDL BioPharma logo are considered trademarks of PDL BioPharma, Inc.
PDL BioPharma, Inc.CONTACT: Ami Knoefler, Senior Director, Corporate and Investor Relations,+1-510-284-8851, or ami.knoefler@pdl.com, or James R. Goff, SeniorDirector, Investor Relations, +1-510-574-1421, or james.goff@pdl.com, bothof PDL BioPharma, Inc.
Web site: http://www.pdl.com/
